Ambu will be distributing Intronix Technologies' Innovative Myoguide™ System Worldwide

TORONTO, Oct. 27, 2014 /PRNewswire/ -- Ambu, a leading global supplier of medical devices, has signed a distribution agreement with Intronix Technologies. Intronix Technologies' innovative Myoguide EMG guided injection system will be available through Ambu's worldwide network of distributors, which already services Ambu's customers locally. The revolutionary Myoguide™ Needle EMG Guided Injection System has breakthrough technology that gives practitioners a superior way to deliver targeted injections. Myoguide™ uses the patient's muscle signals to provide ongoing visual and audio feedback, during the needle insertion, to help find focal areas responsible for pain and spasticity.

Developed by the Canadian-based innovator, Intronix Technologies Corp. (http://www.intronixtech.com), the Myoguide™ system detects critical information about the tissues targeted for injection. It then provides instant reporting that increases the odds for successful, accurately measured injections, thus helping minimize mistakes, inaccurate dosages and potential side effects.

Myoguide™ is most frequently used to help direct injections with Botox® and similar drugs. Myoguide™ uses an innovative signal display and high fidelity audio feedback to help clinicians find the optimal injection sites to help manage myofascial pain, spasticity, fibromyalgia, and even cosmetics injections.

"We are pleased to join forces with Ambu to provide our clinician customers with Ambu's Neuroline hypodermic needle electrodes and surface electrode product lines. This will present a complete clinical package for clinicians managing myofascial pain, movement disorders, spasticity and cosmetic applications," says Dr. Evan Friedman, President of Intronix Technologies. "Ambu has a great reputation of manufacturing and distributing excellent medical devices, and we are proud to be a part of the team. Ambu has a solid distribution network and will give Myoguide full exposure throughout Ambu's extensive worldwide healthcare community."

Intronix (booth 306) and Ambu USA (booth 404) will be at the American Academy of Physical Medicine and Rehabilitation (AAPM&R) Annual Assembly, November 13–16, 2014 at the San Diego Convention Center.

Click here to view the full news release.